L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,835	5,047	7,395	16,108	4,910
Short-Term Investments	16,108	7,729	5,608	3,108	3,306
Cash & Short-Term Investments	19,943	12,776	13,003	19,216	8,216
Cash Growth	56.10%	-1.75%	-32.33%	133.88%	68.81%
Accounts Receivable	14,980	9,839	5,780	1,526	3,084
Other Receivables	290.26	1,066	223.05	635.92	203.53
Receivables	16,015	10,905	6,003	2,162	3,309
Inventory	24,551	19,089	16,366	13,856	19,358
Prepaid Expenses	525.95	656.55	444.63	688.1	310.2
Other Current Assets	2,532	990.85	330.62	2,042	851.06
Total Current Assets	63,566	44,417	36,147	37,964	32,044
Property, Plant & Equipment	10,005	9,012	8,514	9,271	7,890
Long-Term Investments	577.5	1,049	64.15	1,203	1,755
Goodwill	-	-	-	-	244.11
Other Intangible Assets	998.17	798.73	715.11	1,209	836.23
Long-Term Accounts Receivable	1,807	1,281	2,385	5,200	5,006
Long-Term Deferred Tax Assets	5,009	5,516	3,902	3,591	8,515
Long-Term Deferred Charges	-	-	106.09	223.63	427.86
Other Long-Term Assets	798.55	387.38	829.96	623.29	2,278
Total Assets	83,061	62,762	52,663	59,285	58,995
Accounts Payable	3,347	2,047	2,437	498.73	1,384
Accrued Expenses	851.44	685.87	589.86	606.95	791.83
Short-Term Debt	20,558	10,040	20,406	6,692	12,434
Current Portion of Long-Term Debt	800	100	2,800	-	3,128
Current Portion of Leases	669.07	828.69	750.57	636.63	572.79
Current Income Taxes Payable	7.29	0.35	54.09	0.89	3.59
Other Current Liabilities	12,841	9,062	10,943	4,177	1,350
Total Current Liabilities	39,074	22,763	37,981	12,613	19,664
Long-Term Debt	1,000	1,700	-	13,608	2,100
Long-Term Leases	369.63	845.16	1,244	1,518	1,751
Long-Term Deferred Tax Liabilities	1,569	1,361	1,047	-	-
Other Long-Term Liabilities	1,958	3,274	55.37	5,429	54.28
Total Liabilities	47,028	32,175	41,902	34,499	24,832
Common Stock	9,968	9,968	6,703	6,696	6,635
Additional Paid-In Capital	90,386	90,386	68,174	67,992	63,616
Retained Earnings	-58,746	-67,849	-65,348	-51,884	-40,051
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09
Comprehensive Income & Other	887.93	2,846	2,740	1,663	1,415
Total Common Equity	42,496	35,351	12,268	24,467	31,615
Minority Interest	-6,463	-4,764	-1,507	319.82	2,548
Shareholders' Equity	36,033	30,587	10,762	24,787	34,163
Total Liabilities & Equity	83,061	62,762	52,663	59,285	58,995
Total Debt	23,397	13,513	25,201	22,456	19,986
Net Cash (Debt)	-3,454	-737.76	-12,198	-3,240	-11,770
Net Cash Per Share	-158.80	-45.44	-910.57	-242.05	-989.82
Filing Date Shares Outstanding	19.89	19.94	13.41	13.39	13.24
Total Common Shares Outstanding	19.89	19.94	13.41	13.39	13.27
Working Capital	24,492	21,654	-1,834	25,351	12,380
Book Value Per Share	2136.66	1773.17	915.17	1826.89	2382.37
Tangible Book Value	41,498	34,553	11,553	23,258	30,534
Tangible Book Value Per Share	2086.47	1733.11	861.82	1736.61	2300.96
Land	737.02	737.02	737.02	737.02	1,079
Buildings	2,502	2,502	2,502	2,502	3,682
Machinery	16,491	14,307	12,330	11,671	5,884
Construction In Progress	59	-	-	-	225.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.